# US Vascular Embolization Market > US Vascular Embolization Market Research Report: Size, Share, Trend Analysis By Embolization Technique (Coiling Devices, Non-coiling Devices) and By Applications (Peripheral Vascular Disease, Oncology, Neurology, Urology, Other) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 9.9% - **2024:** $ 511.59 Million - **2025:** $ 562.24 Million - **2035:** $ 1,445.4 Million - **Key Players:** Medtronic (US), Boston Scientific (US), Terumo (JP), Johnson & Johnson (US), Stryker (US), B. Braun Melsungen AG (DE), Cook Medical (US), Abbott Laboratories (US), AngioDynamics (US) **Report ID:** MRFR/HC/14126-HCR · **Pages:** 100 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-vascular-embolization-market-15653 --- ## Market Summary ## **US Vascular Embolization Market Overview** As per MRFR analysis, the US Vascular Embolization Market Size was estimated at 465.92 (USD Million) in 2023. The US Vascular Embolization Market Industry is expected to grow from 512.05(USD Million) in 2024 to 1,445.9 (USD Million) by 2035. The US Vascular Embolization Market CAGR (growth rate) is expected to be around 9.897% during the forecast period (2025 - 2035). ### **Key US Vascular Embolization Market Trends Highlighted** The US Vascular Embolization Market is experiencing significant trends driven by the rising prevalence of vascular diseases and an increased focus on minimally invasive procedures. The aging population in the US contributes to a higher incidence of conditions that require embolization therapies, such as cancer and vascular malformations. Technological advancements in embolization devices, including improved materials and precision delivery systems, are enhancing treatment outcomes and are vital market drivers. Additionally, there is a growing emphasis on outpatient procedures, which align with healthcare policies aimed at reducing hospital stays and costs, further bolstering the market. Opportunities are emerging in the field of bioabsorbable embolic agents, which are gaining attention due to their potential benefits such as reduced long-term complications and the elimination of permanent foreign bodies in patients. This presents an avenue for innovation and growth within the US market. Furthermore, the availability of various product types, such as liquid embolics, particles, and coils, provides medical professionals with multiple options tailored to specific patient needs, promoting adoption rates. Recent trends reflect an increasing collaboration between medical device companies and hospitals to develop user-friendly and efficient systems for embolization procedures. This focus on partnership drives better education for healthcare professionals and improved patient outcomes. The evolution of regulatory support in the US also encourages innovation, allowing new products to enter the market more rapidly. Overall, these market dynamics underscore a robust landscape for the vascular embolization sector in the US. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **US Vascular Embolization Market Drivers** ### **Rising Incidence of Vascular Diseases** The increasing prevalence of vascular diseases in the United States is a significant driver for the US Vascular Embolization Market Industry. According to the Centers for Disease Control and Prevention, approximately 29 million adults in the US are diagnosed with some form of cardiovascular disease, which encompasses a spectrum of vascular issues that often necessitate embolization procedures. As the population ages and lifestyle-related diseases become more prominent, the demand for effective treatments such as vascular embolization is projected to rise. Additionally, organizations such as the American Heart Association advocate for awareness and treatment of cardiovascular conditions, thereby increasing the need for innovative embolization therapies. This proactivity in management and increased patient load directly correlates with the expanding US Vascular Embolization Market. ### **Technological Advancements in Embolization Techniques** Significant advancements in medical technology are reshaping the US Vascular Embolization Market Industry. The introduction of minimally invasive techniques and advanced embolization agents has improved procedural outcomes and patient recovery times. For example, the approval of novel embolic agents and device systems facilitates more precise and effective interventions. The U.S. Food and Drug Administration supports innovation in this field, emphasizing the importance of Research and Development in creating safer and more efficient embolization solutions. This influx of advanced technologies is expected to optimize treatments, leading to increased adoption rates and growth within the US Vascular Embolization Market. ### **Growth in Surgical Procedures Related to Cancer Treatment** The rising number of cancer diagnoses in the United States significantly contributes to the growth of the US Vascular Embolization Market Industry, as embolization is often employed in the palliative treatment of tumors. The American Cancer Society reports that there are over 1.9 million new cancer cases annually in the US. Many of these cases require embolization to manage blood flow to tumors effectively. This trend influences hospitals and clinics to incorporate embolization techniques into their cancer treatment protocols, creating a steady demand for embolization products and services within the market. ## **US Vascular Embolization Market Segment Insights** ### **Vascular Embolization Market Embolization Technique Insights** The Embolization Technique segment within the US Vascular Embolization Market holds significant potential due to its essential role in treating various vascular conditions, particularly in interventional procedures for conditions such as uterine fibroids, liver tumors, and brain aneurysms. This segment comprises various methods that are primarily distinguished by the devices utilized, namely Coiling Devices and Non-coiling Devices. Coiling Devices, which are crucial for managing aneurysms and preventing hemorrhagic complications, have gained prominence due to their minimally invasive nature and ability to be deployed via catheterization, thereby reducing recovery times for patients. Conversely, Non-coiling Devices encompass a broader range of embolic materials, including liquids, particles, and vascular plugs, which are particularly important in treating hypervascular tumors and managing arteriovenous malformations. The segmentation of the Embolization Technique reveals a strategic approach to cater to specific medical needs, as each type of device plays a unique role in achieving embolization goals. The growing prevalence of chronic diseases and an aging population has driven demand for effective vascular interventions, highlighting the importance of innovative solutions that this segment offers. Furthermore, advancements in technology, such as the development of bioresorbable materials in Non-coiling Devices, are enhancing the effectiveness and safety of procedures, which in turn could contribute to improved patient outcomes and expand the market landscape. Regulatory bodies encourage the development of these techniques, recognizing the critical role they play in enhancing healthcare efficiency in the US. Despite challenges such as the high cost of advanced embolization devices and the need for skilled healthcare professionals, the opportunities for growth in this segment remain robust, fueled by rising healthcare expenditures and increasing patient awareness regarding minimally invasive treatment options. Overall, the insights into the Embolization Technique segment reflect a complex yet promising component of the US Vascular Embolization Market. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Vascular Embolization Market Application Insights** The US [Vascular Embolization](../../../reports/vascular-embolization-market-11872) Market is exhibiting significant potential within its Application segment, which encompasses various key therapeutic areas. The rise in peripheral vascular diseases is leading to increased demand for embolization procedures, positioning this area as a growing focus within the market. Oncology represents another vital segment, as the need for targeted treatments for tumors drives innovative approaches, highlighting the importance of embolization in minimizing systemic effects. Neurology is also a prominent area, with embolization techniques being utilized for conditions such as arteriovenous malformations and tumors, improving patient outcomes. In the context of urology, embolization is making strides in the treatment of kidney tumors and other related vascular concerns. The other category includes diverse applications that cater to various medical conditions, each contributing to the overall growth of the US Vascular Embolization Market. As the healthcare sector in the US progresses, the demand for advanced, minimally invasive interventions across these applications is expected to rise, further underlining the sector's importance to the broader landscape of medical treatments. Enhanced technology and ongoing research efforts are anticipated to drive innovations and improvements in patient care across all these segments, reinforcing their significance in the overall market dynamics. ## **US Vascular Embolization Market Key Players and Competitive Insights** The US Vascular Embolization Market is characterized by robust competition driven by advancements in medical technologies and an increasing prevalence of vascular diseases that necessitate innovative treatment options. This market features a range of players, including large multinational corporations and smaller enterprises innovating in specialized segments. Recent trends suggest that the demand for minimally invasive procedures is paving the way for new product developments, as companies strive to improve patient outcomes while optimizing procedural efficiency. Pricing strategies, distribution channels, and technological advancements are critical factors influencing competitive dynamics, with organizations continuously seeking to gain market share through strategic partnerships, mergers, and acquisitions. Abbott has established a formidable presence in the US Vascular Embolization Market, leveraging its extensive portfolio of medical devices and technologies. The company’s strong reputation is built on a foundation of research and development, allowing it to deliver innovative solutions tailored for vascular interventions. Abbott benefits from its well-integrated supply chain and robust distribution network, which ensures efficient product availability across various healthcare settings. The company's commitment to advancing healthcare practices through its cutting-edge embolization products has positioned it favorably against competitors. Moreover, Abbott's emphasis on quality assurance and regulatory compliance further enhances its credibility and trust among healthcare professionals and institutions. Hologic is another key player in the US Vascular Embolization Market, recognized for its dedication to women's health and its innovative approach to diagnostic and treatment solutions. The company has carved out a niche with its advanced imaging technologies and biopsy systems, which are integral for guiding vascular embolization procedures. Hologic's strategic focus on technological innovation has resulted in the development of products that enhance the precision and effectiveness of embolization treatments. Its ongoing investments in research and development, alongside a series of strategic acquisitions, have allowed Hologic to expand its capabilities and market reach within the US. The strength of Hologic lies in its commitment to providing comprehensive solutions that support healthcare providers in delivering high-quality care while improving patient safety and outcomes in vascular interventions. ### **Key Companies in the US Vascular Embolization Market Include** ## **US Vascular Embolization Market Industry Developments** The US Vascular Embolization Market has witnessed several significant developments recently, especially with firms like Medtronic and Boston Scientific launching new products aimed at improving treatment efficiency. In August 2023, Merit Medical Systems expanded its product portfolio through the acquisition of a key medical imaging technology, enhancing its capabilities in vascular therapies. Abbott has also been active, focusing on Research and Development to innovate its embolization devices, responding to the rising demand for minimally invasive procedures. Currently, the broader market is seeing a valuation increase, attributed to the growing prevalence of cardiovascular diseases and the aging population in the US. This increase has been particularly beneficial for companies like Terumo and AngioDynamics, which are strategically positioning themselves to capture market share. In the past few years, the Vascular Embolization Market has experienced a surge in investment and mergers, with Hologic and CryoLife merging operations to streamline efficacy. The overall trend reflects an adaptive industry responding to healthcare needs, regulatory changes, and technological advancements, underpinning a vibrant and competitive market landscape. ## **US Vascular Embolization Market Segmentation Insights** ### **Vascular Embolization Market Embolization Technique Outlook** ### **Vascular Embolization Market Application Outlook** ## Market Drivers ### Increased Awareness and Education There is a growing awareness and education regarding vascular diseases and their treatment options among both healthcare professionals and patients. This trend is fostering a more informed patient population that actively seeks out embolization procedures as viable treatment alternatives. Educational initiatives and outreach programs are likely to contribute to the rising demand for vascular embolization, as patients become more knowledgeable about their health conditions and the benefits of minimally invasive treatments. Consequently, this heightened awareness is expected to positively impact the vascular embolization market. ### Advancements in Imaging Technologies Innovations in imaging technologies are playing a crucial role in the vascular embolization market. Enhanced imaging modalities, such as 3D angiography and intraoperative imaging, allow for more precise targeting of embolization procedures. These advancements improve patient outcomes by increasing the accuracy of interventions and reducing the likelihood of complications. The integration of advanced imaging techniques is expected to bolster the growth of the vascular embolization market, as healthcare facilities adopt these technologies to enhance procedural efficacy and safety. ### Supportive Healthcare Policies and Funding Supportive healthcare policies and funding initiatives are emerging as key drivers for the vascular embolization market. Government programs and private insurance plans are increasingly covering embolization procedures, making them more accessible to patients. This financial support is crucial in encouraging healthcare providers to offer these services, as reimbursement rates for embolization procedures have shown improvement. As a result, the vascular embolization market is likely to benefit from these favorable policies, which enhance patient access to necessary treatments and promote the growth of the industry. ### Aging Population and Associated Health Issues The aging population in the United States is contributing significantly to the growth of the vascular embolization market. As individuals age, they become more susceptible to various vascular diseases, including aneurysms and arteriovenous malformations. The U.S. Census Bureau projects that by 2030, approximately 20% of the population will be 65 years or older, leading to an increased incidence of conditions requiring embolization. This demographic shift is likely to drive demand for vascular embolization procedures, as healthcare providers seek effective solutions to manage age-related vascular health issues. ### Rising Demand for Minimally Invasive Procedures The vascular embolization market is experiencing a notable increase in demand for minimally invasive procedures. Patients and healthcare providers are increasingly favoring these techniques due to their reduced recovery times and lower risk of complications compared to traditional surgical methods. This shift is reflected in the growing number of embolization procedures performed annually, which has been reported to increase by approximately 10% in recent years. As a result, the vascular embolization market is likely to expand, driven by the need for effective and less invasive treatment options for conditions such as tumors and vascular malformations. ## Future Outlook The [Vascular Embolization Market](https://www.marketresearchfuture.com/reports/vascular-embolization-market-11872) is projected to grow at a 9.9% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of vascular diseases, and rising healthcare expenditure. **New opportunities:** - Development of biodegradable embolic agents for enhanced patient safety. Expansion of telemedicine platforms for remote embolization consultations. Investment in AI-driven imaging technologies to improve procedural accuracy. By 2035, the vascular embolization market is expected to achieve substantial growth and innovation. ## Segment Insights ### By Technique: Coiling Devices (Largest) vs. Non-coiling Devices (Fastest-Growing) In the US vascular embolization market, the coiling devices segment holds a significant share, driven by their established use in various embolization procedures. The segment benefits from advanced technology integration and a broad range of applications, making it a preferred choice among practitioners. Conversely, non-coiling devices, although currently smaller in market share, are gaining traction due to innovations and increasing adoption in specific clinical scenarios, attracting interest from both healthcare providers and patients. The growth trends within this segment illustrate notable advances, particularly in non-coiling devices which are witnessing rapid development and improved clinical efficacy. Factors such as increasing incidence rates of vascular diseases and a push towards minimally invasive procedures are propelling the demand for both coiling and non-coiling technologies. Moreover, ongoing research and development efforts continue to enhance device performance and broaden their applications, fostering competitive dynamics in the market. Technique: Coiling Devices (Dominant) vs. Non-coiling Devices (Emerging) Coiling devices are well-established in the embolization landscape, known for their efficacy in addressing aneurysms and vascular lesions. Their dominance stems from a reliable track record, ease of use, and effectiveness in various clinical scenarios. Meanwhile, non-coiling devices, although emerging, showcase innovative designs tailored to expanding indications and greater patient safety. As technology evolves, these devices, such as particulate embolics and liquid embolics, are transforming treatment paradigms, promising enhanced precision in vascular occlusion. Driven by both clinical need and technological advancements, the competitive landscape is expected to shift, with non-coiling devices gaining traction in specialized applications. ### By Application: Oncology (Largest) vs. Peripheral Vascular Disease (Fastest-Growing) In the US vascular embolization market, the application segment is dominated by Oncology, which holds the largest market share due to increasing incidences of cancer that require effective treatment options. Peripheral Vascular Disease follows closely, representing a significant portion of the market, as lifestyle diseases contribute to its prevalence. Neurology, Urology, and other applications also contribute but to a lesser extent, indicating distinctive niches within this market. The growth trends within this segment are driven by advancements in medical technology and an increasing focus on minimally invasive procedures. Oncology remains a key area of investment for healthcare providers, with innovations augmenting treatment efficacy. Furthermore, Peripheral Vascular Disease is emerging rapidly, spurred by rising awareness and screening initiatives, suggesting strong future potential as treatment options continue to evolve. Oncology (Dominant) vs. Peripheral Vascular Disease (Emerging) Oncology is a dominant application in the US vascular embolization market, characterized by a broad range of treatment options and high demand due to rising cancer rates. The increasing adoption of embolization techniques for tumor treatment is significantly impacting market dynamics. In contrast, Peripheral Vascular Disease is an emerging application area, propelled by a growing aging population and rising lifestyle-related health issues. As non-invasive therapies become more accepted, both treatments for oncology and peripheral vascular conditions are expected to play crucial roles in shaping market trends. The focus remains on improving patient outcomes, enhancing procedure safety, and expanding the therapeutic scope of embolization techniques. ## Competitive Benchmarking The vascular embolization market is characterized by a dynamic competitive landscape, driven by technological advancements and an increasing prevalence of vascular diseases. Key players such as Medtronic (US), Boston Scientific (US), and Johnson & Johnson (US) are at the forefront, leveraging innovation and strategic partnerships to enhance their market positions. Medtronic (US) focuses on developing cutting-edge embolization devices, while Boston Scientific (US) emphasizes expanding its product portfolio through acquisitions and collaborations. Johnson & Johnson (US) appears to be concentrating on integrating digital health solutions into its offerings, thereby enhancing patient outcomes and operational efficiency. Collectively, these strategies contribute to a competitive environment that is increasingly centered around innovation and patient-centric solutions.In terms of business tactics, companies are localizing manufacturing and optimizing supply chains to enhance responsiveness to market demands. The vascular embolization market is moderately fragmented, with several players vying for market share. However, the influence of major companies is substantial, as they set industry standards and drive technological advancements. This competitive structure allows for a diverse range of products and services, catering to various patient needs and preferences. In October Medtronic (US) announced the launch of its latest embolization device, which incorporates advanced imaging technology to improve procedural accuracy. This strategic move is significant as it not only enhances Medtronic's product offerings but also positions the company as a leader in innovation within the market. The integration of imaging technology is likely to attract healthcare providers seeking to improve patient outcomes and procedural efficiency. In September Boston Scientific (US) completed the acquisition of a smaller firm specializing in embolization materials, thereby expanding its product range and market reach. This acquisition is indicative of Boston Scientific's strategy to bolster its competitive edge through diversification. By integrating new technologies and products, the company aims to enhance its value proposition to healthcare providers and patients alike. In August Johnson & Johnson (US) entered into a partnership with a tech firm to develop AI-driven solutions for embolization procedures. This collaboration underscores the growing trend of digitalization in healthcare, as AI technologies are expected to streamline workflows and improve decision-making processes. Such strategic alliances are likely to redefine competitive dynamics, as companies that effectively leverage technology will gain a substantial advantage. As of November the vascular embolization market is witnessing trends such as digitalization, sustainability, and AI integration, which are reshaping competitive strategies. The emphasis on strategic alliances is becoming increasingly pronounced, as companies recognize the value of collaboration in driving innovation. Looking ahead, competitive differentiation is expected to evolve, with a shift from price-based competition to a focus on technological innovation, supply chain reliability, and enhanced patient outcomes. This transition suggests that companies that prioritize these aspects will likely emerge as leaders in the vascular embolization market. ## Recent News & Developments The US Vascular Embolization Market has witnessed several significant developments recently, especially with firms like Medtronic and Boston Scientific launching new products aimed at improving treatment efficiency. In August 2023, Merit Medical Systems expanded its product portfolio through the acquisition of a key medical imaging technology, enhancing its capabilities in vascular therapies. Abbott has also been active, focusing on Research and Development to innovate its embolization devices, responding to the rising demand for minimally invasive procedures. Currently, the broader market is seeing a valuation increase, attributed to the growing prevalence of cardiovascular diseases and the aging population in the US. This increase has been particularly beneficial for companies like Terumo and AngioDynamics, which are strategically positioning themselves to capture market share. In the past few years, the Vascular Embolization Market has experienced a surge in investment and mergers, with Hologic and CryoLife merging operations to streamline efficacy. The overall trend reflects an adaptive industry responding to healthcare needs, regulatory changes, and technological advancements, underpinning a vibrant and competitive market landscape. ## Report Scope | MARKET SIZE 2024 | 511.59(USD Million) | | --- | --- | | MARKET SIZE 2025 | 562.24(USD Million) | | MARKET SIZE 2035 | 1445.4(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 9.9% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Medtronic (US), Boston Scientific (US), Terumo (JP), Johnson & Johnson (US), Stryker (US), B. Braun Melsungen AG (DE), Cook Medical (US), Abbott Laboratories (US), AngioDynamics (US) | | Segments Covered | Technique, Application | | Key Market Opportunities | Advancements in minimally invasive techniques enhance growth potential in the vascular embolization market. | | Key Market Dynamics | Technological advancements and regulatory changes drive innovation in the vascular embolization market, enhancing treatment options. | | Countries Covered | US | ## Frequently Asked Questions **Q: What was the market valuation of the US vascular embolization market in 2024?** A: The market valuation was $511.59 Million in 2024. **Q: What is the projected market valuation for the US vascular embolization market by 2035?** A: The projected valuation for 2035 is $1445.4 Million. **Q: What is the expected CAGR for the US vascular embolization market during the forecast period 2025 - 2035?** A: The expected CAGR during the forecast period is 9.9%. **Q: Which companies are considered key players in the US vascular embolization market?** A: Key players include Medtronic, Boston Scientific, Terumo, Johnson & Johnson, Stryker, B. Braun Melsungen AG, Cook Medical, Abbott Laboratories, and AngioDynamics. **Q: What are the two main techniques used in the US vascular embolization market?** A: The two main techniques are coiling devices and non-coiling devices. **Q: What was the market size for coiling devices in 2024?** A: The market size for coiling devices was $200 Million in 2024. **Q: What is the projected market size for non-coiling devices by 2035?** A: The projected market size for non-coiling devices by 2035 is $845.4 Million. **Q: Which application segment had the highest market size in 2024?** A: The oncology application segment had the highest market size at $150 Million in 2024. **Q: What is the expected market size for the neurology application segment by 2035?** A: The expected market size for the neurology application segment by 2035 is $350 Million. **Q: How does the market size for peripheral vascular disease compare to other application segments in 2024?** A: In 2024, the market size for peripheral vascular disease was $100 Million, making it one of the smaller segments compared to oncology and neurology. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-vascular-embolization-market-15653*